Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine premedication in elderly subjects
NL-OMON42654Phase 2Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine (3 arms), sponsored by University Medical Center Groningen. Primary endpoints: Hypotension incidence, Bradycardia incidence and 1 more. Started Mar 2016; status: active, not recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NL-OMON42654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42654.